Cingulate Inc. Short-term Investments
Cingulate Inc. (CING) had Short-term Investments of $933 as of 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Balance Sheet › Assets, Current
us-gaap:ShortTermInvestments · last filed 2023-03-10
- 2022-03-31: Short-term Investments $933.00.
- 2021-12-31: Short-term Investments $933.00.
- 2020-12-31: Short-term Investments $933.00.
| Period end | Short-term Investments |
|---|---|
| 2022-03-31 | $933.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $933.00 10-K · filed 2023-03-10 |
| 2020-12-31 | $933.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |